Figure 3.

Gemcitabine release profiles from PLGem and GemPo. Gemcitabine release profiles from (A) PLGem and (B) GemPo nanoparticles were evaluated in PBS or human pancreatic carcinoma (PANC1) cell lysates. Values on the Y-axis represent the amount of Gemcitabine released from the nanoparticles in a defined volume.

Papa et al. BMC Cancer 2012 12:419   doi:10.1186/1471-2407-12-419
Download authors' original image